Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04295486
PHASE2

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

Sponsor: University of Miami

View on ClinicalTrials.gov

Summary

This research study is attempting to answer the question of whether 81 mg aspirin once daily is as effective as 81 mg aspirin twice daily in preventing blood clots after total joint replacement surgery.

Official title: Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For Venous Thromboembolism (VTE) Following Total Joint Arthroplasty - A Multi-center Prospective Randomized Control Trial.

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

5478

Start Date

2021-03-01

Completion Date

2027-03-01

Last Updated

2026-03-11

Healthy Volunteers

No

Interventions

DRUG

Aspirin

Non-enteric coated 81 mg Aspirin tablet.

Locations (1)

University of Miami Hospital

Miami, Florida, United States